30 years of historical data (1996–2025) · Healthcare · Medical - Instruments & Supplies
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
DENTSPLY SIRONA Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 21.1x P/FCF, 5% below the 5-year average of 22.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.2B | $2.3B | $3.9B | $7.5B | $6.9B | $12.3B | $11.5B | $12.7B | $8.3B | $15.1B | $12.8B |
| Enterprise Value | $4.3B | $4.4B | $5.9B | $9.5B | $8.6B | $14.2B | $13.5B | $13.9B | $9.7B | $16.4B | $13.9B |
| P/E Ratio → | -3.65 | — | — | — | — | 29.83 | — | 48.37 | — | — | 29.76 |
| P/S Ratio | 0.60 | 0.62 | 1.02 | 1.90 | 1.75 | 2.90 | 3.44 | 3.16 | 2.09 | 3.78 | 3.42 |
| P/B Ratio | 1.63 | 1.70 | 1.98 | 2.29 | 1.80 | 2.46 | 2.33 | 2.49 | 1.63 | 2.27 | 1.57 |
| P/FCF | 21.11 | 21.91 | 13.73 | 33.09 | 18.65 | 23.85 | 20.42 | 24.90 | 26.77 | 33.49 | 29.25 |
| P/OCF | 9.34 | 9.70 | 8.37 | 20.01 | 13.27 | 18.70 | 17.68 | 20.07 | 16.70 | 25.09 | 22.71 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
DENTSPLY SIRONA Inc.'s enterprise value stands at 7.2x EBITDA, 64% below its 5-year average of 19.7x. The Healthcare sector median is 14.4x, placing the stock at a 50% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.20 | 1.54 | 2.40 | 2.20 | 3.37 | 4.04 | 3.45 | 2.43 | 4.10 | 3.72 |
| EV / EBITDA | 7.18 | 7.32 | — | 36.86 | — | 14.93 | 40.77 | 20.55 | — | — | 19.16 |
| EV / EBIT | 17.21 | — | — | — | — | 23.50 | — | 38.06 | — | — | 29.19 |
| EV / FCF | — | 42.51 | 20.84 | 41.71 | 23.49 | 27.65 | 24.01 | 27.25 | 31.09 | 36.35 | 31.83 |
Margins and return-on-capital ratios measuring operating efficiency
DENTSPLY SIRONA Inc. earns an operating margin of 6.8%. Operating margins have expanded from -2.1% to 6.8% over the past 3 years, signaling improving operational efficiency. A negative ROE of -36.4% indicates the company is currently destroying shareholder equity. ROIC of 5.1% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.0% | 50.0% | 51.6% | 52.6% | 54.2% | 55.5% | 49.6% | 53.8% | 51.9% | 54.8% | 53.4% |
| Operating Margin | 6.8% | 6.8% | -23.2% | -2.1% | -23.9% | 14.4% | -0.1% | 8.8% | -24.0% | -39.7% | 12.1% |
| Net Profit Margin | -16.3% | -16.3% | -24.0% | -3.3% | -24.2% | 9.7% | -2.2% | 6.4% | -25.4% | -38.8% | 11.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -36.4% | -36.4% | -34.8% | -3.7% | -21.6% | 8.3% | -1.5% | 5.0% | -17.2% | -21.0% | 8.2% |
| ROA | -10.7% | -10.7% | -13.9% | -1.8% | -11.3% | 4.4% | -0.8% | 3.0% | -10.6% | -14.1% | 5.4% |
| ROIC | 5.1% | 5.1% | -14.3% | -1.2% | -11.2% | 6.6% | -0.0% | 4.1% | -10.0% | -13.8% | 5.5% |
| ROCE | 6.1% | 6.1% | -17.4% | -1.4% | -13.0% | 7.6% | -0.0% | 4.6% | -11.2% | -15.6% | 6.1% |
Solvency and debt-coverage ratios — lower is generally safer
DENTSPLY SIRONA Inc. carries a Debt/EBITDA ratio of 4.1x, which is highly leveraged (24% above the sector average of 3.3x). Net debt stands at $2.1B ($2.5B total debt minus $326M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.84 | 1.84 | 1.17 | 0.70 | 0.56 | 0.46 | 0.50 | 0.31 | 0.32 | 0.24 | 0.19 |
| Debt / EBITDA | 4.09 | 4.09 | — | 8.91 | — | 2.40 | 7.42 | 2.37 | — | — | 2.08 |
| Net Debt / Equity | — | 1.60 | 1.03 | 0.60 | 0.47 | 0.39 | 0.41 | 0.23 | 0.26 | 0.19 | 0.14 |
| Net Debt / EBITDA | 3.55 | 3.55 | — | 7.62 | — | 2.05 | 6.09 | 1.77 | — | — | 1.55 |
| Debt / FCF | — | 20.60 | 7.12 | 8.62 | 4.84 | 3.80 | 3.59 | 2.34 | 4.32 | 2.86 | 2.58 |
| Interest Coverage | -4.52 | -4.52 | -12.57 | -1.16 | -15.23 | 9.93 | -0.06 | 12.41 | -24.69 | -40.93 | 13.28 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.51x means DENTSPLY SIRONA Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.03x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 1.38x to 1.51x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.51 | 1.51 | 1.10 | 1.38 | 1.62 | 1.47 | 1.31 | 2.01 | 1.86 | 2.12 | 2.44 |
| Quick Ratio | 1.03 | 1.03 | 0.74 | 0.95 | 1.08 | 1.06 | 0.96 | 1.45 | 1.27 | 1.46 | 1.77 |
| Cash Ratio | 0.24 | 0.24 | 0.17 | 0.23 | 0.31 | 0.27 | 0.32 | 0.41 | 0.31 | 0.34 | 0.50 |
| Asset Turnover | — | 0.68 | 0.66 | 0.54 | 0.51 | 0.46 | 0.36 | 0.47 | 0.46 | 0.38 | 0.32 |
| Inventory Turnover | 2.87 | 2.87 | 3.25 | 3.01 | 2.86 | 3.66 | 3.54 | 3.31 | 3.20 | 2.90 | 3.37 |
| Days Sales Outstanding | — | 68.24 | 58.32 | 69.59 | 63.75 | 69.27 | 77.18 | 75.14 | 64.27 | 68.20 | 61.98 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
DENTSPLY SIRONA Inc. returns 5.9% to shareholders annually primarily through dividends.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 5.9% | 5.6% | 3.3% | 1.5% | 1.5% | 0.7% | 0.8% | 0.6% | 0.9% | 0.5% | 0.5% |
| Payout Ratio | — | — | — | — | — | 22.4% | — | 31.6% | — | — | 15.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 3.4% | — | 2.1% | — | — | 3.4% |
| FCF Yield | 4.7% | 4.6% | 7.3% | 3.0% | 5.4% | 4.2% | 4.9% | 4.0% | 3.7% | 3.0% | 3.4% |
| Buyback Yield | 0.0% | 0.0% | 6.5% | 4.0% | 2.2% | 1.6% | 2.0% | 2.0% | 3.0% | 2.7% | 6.4% |
| Total Shareholder Yield | 5.9% | 5.6% | 9.7% | 5.5% | 3.7% | 2.4% | 2.8% | 2.7% | 3.9% | 3.2% | 6.9% |
| Shares Outstanding | — | $199M | $203M | $212M | $216M | $220M | $219M | $224M | $224M | $229M | $222M |
Compare XRAY with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $2B | -3.7 | 7.2 | 21.1 | 50.0% | 6.8% | -36.4% | 5.1% | 4.1 | |
| $12B | 29.8 | 13.9 | 24.6 | 68.3% | 15.3% | 10.4% | 15.4% | 0.1 | |
| $8B | 21.6 | 10.9 | 14.1 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 | |
| $4B | 86.7 | 13.3 | 17.5 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 | |
| $4B | 29.3 | 13.1 | 17.2 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 | |
| $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 | |
| $1B | 25.2 | 10.2 | 7.8 | 52.8% | 10.3% | 4.7% | 5.8% | 4.3 | |
| $1B | -115.8 | 77.7 | 29.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 | |
| $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 | |
| $16B | 23.5 | 9.5 | 11.1 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 | |
| $45B | 43.7 | 31.6 | 43.1 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 | |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Align Technology, Inc..
Start ComparisonQuick answers to the most common questions about buying XRAY stock.
DENTSPLY SIRONA Inc.'s current P/E ratio is -3.7x. The historical average is 26.9x.
DENTSPLY SIRONA Inc.'s current EV/EBITDA is 7.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.3x.
DENTSPLY SIRONA Inc.'s return on equity (ROE) is -36.4%. The historical average is 6.8%.
Based on historical data, DENTSPLY SIRONA Inc. is trading at a P/E of -3.7x. Compare with industry peers and growth rates for a complete picture.
DENTSPLY SIRONA Inc.'s current dividend yield is 5.86%.
DENTSPLY SIRONA Inc. has 50.0% gross margin and 6.8% operating margin.
DENTSPLY SIRONA Inc.'s Debt/EBITDA ratio is 4.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.